Use of follistatin to increase muscle mass

Details for Australian Patent Application No. 2012204098 (hide)

Owner The Johns Hopkins University

Inventors Lee, Se-Jin; McPherron, Alexandra C.

Agent Davies Collison Cave

Pub. Number AU-A-2012204098

Parent 2007201968

Filing date 11 July 2012

Wipo publication date 2 August 2012

International Classifications

C12N 15/85 Mutation or genetic engineering - for animal cells

A01K 67/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61P 3/04 Drugs for disorders of the metabolism

A61P 3/06 Drugs for disorders of the metabolism

C07K 14/71 Peptides having more than 20 amino acids

C12N 5/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/22 Undifferentiated human, animal or plant cells, e.g. cell lines - Human cells

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/18 Mutation or genetic engineering

Event Publications

26 July 2012 Complete Application Filed

2 August 2012 Application Open to Public Inspection

  Published as AU-A-2012204098

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012204099-Antibodies directed to HER-3 and uses thereof

2012204097-Novel nucleoside analogs for treatment of viral infections